Total Funding
75
55
Total FundingPost-IPO Equity raised
Growth Score
0 pts
Heat Score
4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
74560
Fortress Biotech is a biopharmaceutical company that focuses on acquiring, developing, and commercializing therapeutic products.
Lindsay Rosenwald: Chairman, President And Chief Executive OfficerPast Role: OpusPoint Partners, Partner- David Jin: VP of Corporate Development
About the Company
Fortress Biotech is a biopharmaceutical company focusing on acquiring, developing, and commercializing high-potential marketed and development-stage drugs and drug candidates. Fortress has 5 marketed products and over 25 programs in development through its majority-owned and majority-controlled partners and partners it founded and holds significant
minority ownership positions. Target therapeutic areas and technologies include oncology, rare diseases, gene and cell therapy, and other areas of high unmet need.
